Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : World Heart Corp - WHRT and TSE/WHT -- Ignore unavailable to you. Want to Upgrade?

To: Dan Hamilton who wrote (241)	3/11/1999 7:45:00 PM
From: Mindshare	Respond to of 500

You are right. I forgot that one. It is very important. Financing is from venture capitalists. I do not know much about the management team, except that they do have medical device sales experience. I am not invested in the company. The two heart surgeons that are currently involved in implanting the device are top notch and very respected. DeBakey would not have allowed the device to be named after him if he didn't think the management team was sound and the device viable. World Heart should know by now what are the blood cell damage and blood clotting levels for the HeartSaver. I think they have a good design. The many device failures during animal trials would worry me though. They need several animal implants with durations of several months with no problems before even considering human trials. I may be missing some data thats been published, so I'll do a better search. Any help would be appreciated. Regards Mindshare

To: Dan Hamilton who wrote (241)	3/11/1999 8:36:00 PM
From: Mindshare	Respond to of 500

Some comments from MicroMed's Management amcity.com